Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia

Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms

(2014) Ahrathy Selathurai et al.   CARDIOVASCULAR RESEARCH

HIF Prolyl 4-Hydroxylase-2 Inhibition Improves Glucose and Lipid Metabolism and Protects Against Obesity and Metabolic Dysfunction

(2014) L. Rahtu-Korpela et al.   DIABETES

Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease

(2014) Eric Olson et al.   VASCULAR MEDICINE

Raised haematocrit concentration and the risk of death and vascular complications after major surgery

(2013) K. M. Musallam et al.   BRITISH JOURNAL OF SURGERY

PHD1 Links Cell-Cycle Progression to Oxygen Sensing through Hydroxylation of the Centrosomal Protein Cep192

(2013) Sandra C. Moser et al.   DEVELOPMENTAL CELL

Late-Breaking Orals

(2012)   Journal of Clinical Hypertension

Activation of the Liver X Receptor Stimulates Trans-intestinal Excretion of Plasma Cholesterol

(2009) Jelske N. van der Veen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism

(2008) Julián Aragonés et al.   NATURE GENETICS